|
PI4K2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.283400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.064000E-03 |
| Normal-vs-Stage2 |
4.403600E-01 |
| Normal-vs-Stage3 |
6.767000E-01 |
| Normal-vs-Stage4 |
8.090300E-02 |
| Stage1-vs-Stage2 |
3.771400E-01 |
| Stage1-vs-Stage3 |
4.097200E-01 |
| Stage1-vs-Stage4 |
8.995200E-01 |
| Stage2-vs-Stage3 |
8.883600E-01 |
| Stage2-vs-Stage4 |
6.218000E-01 |
| Stage3-vs-Stage4 |
5.530400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.818300E-03 |
| Normal-vs-AfricanAmerican |
1.879040E-01 |
| Normal-vs-Asian |
1.887810E-02 |
| Caucasian-vs-AfricanAmerican |
3.666600E-01 |
| Caucasian-vs-Asian |
5.432400E-01 |
| AfricanAmerican-vs-Asian |
3.792600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.247890E-02 |
| Normal-vs-Female |
5.657800E-03 |
| Male-vs-Female |
4.804200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.58440000000471E-05 |
| Normal-vs-Extreme_Weight |
3.59970000000098E-05 |
| Normal-vs-Obese |
3.031200E-01 |
| Normal-vs-Extreme_Obese |
5.435800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.839600E-01 |
| Normal_Weight-vs-Obese |
2.806300E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.283630E-01 |
| Extreme_Weight-vs-Obese |
4.730400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.734780E-01 |
| Obese-vs-Extreme_Obese |
9.888000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.317800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.772000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.457300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.842400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.773000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.391600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.548800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.610800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.809420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.813600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.636500E-03 |
| Normal-VS-Type2 PRCC |
9.005800E-02 |
| Normal-VS-KIRP CIMP |
7.485600E-01 |
| Normal-VS-Unclassified PRCC |
2.014400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.851800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.817800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.718000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.420600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.739000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.855000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.616100E-02 |
| Normal-vs-N1 |
4.682800E-01 |
| Normal-vs-N2 |
2.177500E-03 |
| N0-vs-N1 |
4.332400E-01 |
| N0-vs-N2 |
4.033800E-01 |
| N1-vs-N2 |
2.578800E-01 |
|
|
